查找临床试验
已按「肝癌」检索，对应国际通用词 hepatocellular carcinoma
共找到 298 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 22:13，每 5 分钟自动同步Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
United States
年龄 18 Years – 不限
H. Lee Moffitt Cancer Center and Research Institute
Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?
Italy
年龄 18 Years – 不限
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
South Korea
年龄 20 Years – 不限
Asan Medical Center
Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma
South Korea
年龄 19 Years – 不限
Yoon Jun Kim
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
United States、Australia、Canada、France、Germany 等 12 国
年龄 8 Years – 不限
Fore Biotherapeutics
PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)
France
年龄 18 Years – 不限
Hospices Civils de Lyon
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
United States
年龄 18 Years – 不限
RayzeBio, Inc.
Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer
Canada
年龄 18 Years – 不限
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 18 Years – 不限
Daiichi Sankyo
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
United States
年龄 18 Years – 不限
University of California, San Francisco
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
United States
年龄 18 Years – 不限
VA Office of Research and Development
Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)
Netherlands
年龄 18 Years – 不限
Niek Wijnen